| RRC ID |
39045
|
| 著者 |
Nakayama K, Rahman MT, Rahman M, Nakamura K, Ishikawa M, Katagiri H, Sato E, Ishibashi T, Iida K, Ishikawa N, Kyo S.
|
| タイトル |
CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.
|
| ジャーナル |
Int J Oncol
|
| Abstract |
The clinicopathological significance of amplification was investigated of the gene encoding cyclin E (CCNE1) and we assessed whether CCNE1 was a potential target in endometrioid endometrial carcinomas. CCNE1 amplification and CCNE1 or F-box and WD repeat domain-containing 7 (FBXW7) expression in endometrial endometrioid carcinoma was assessed by immunohistochemistry and fluorescence in situ hybridization. CCNE1 knockdown by small interfering RNA (siRNA) was used to assess the CCNE1 function. The results showed that CCNE1 amplification was present in 9 (8.3%) of 108 endometrial carcinomas. CCNE1 amplification was correlated with high histological grade (Grade 3; p=0.0087) and lymphovascular space invasion (p=0.0258). No significant association was observed between CCNE1 amplification and FIGO stage (p=0.851), lymph node metastasis (p=0.078), body mass index (p=0.265), deep myometrial invasion (p=0.256), menopausal status (p=0.289) or patient age (p=0.0817). CCNE1 amplification was significantly correlated with shorter progression-free and overall survival (p=0.0081 and 0.0073, respectively). CCNE1 protein expression or loss of FBXW7 expression in endometrial endometrioid carcinoma tended to be correlated with shorter progression-free and overall survival; however, this difference was not statistically significant. Multivariate analysis showed that CCNE1 amplification was an independent prognostic factor for overall survival but not for progression-free survival (P=0.0454 and 0.2175, respectively). Profound growth inhibition was observed in siRNA-transfected cancer cells with endogenous CCNE1 overexpression compared with that in cancer cells having low CCNE1 expression. CCNE1 amplification was independent of p53, HER2, MLH1 and ARID1A expression but dependent on PTEN expression in endometrial carcinomas. These findings indicated that CCNE1 amplification was critical for the survival of endometrial endometrioid carcinomas. Furthermore, the effects of CCNE1 knockdown were dependent on the CCNE1 expression status, suggesting that CCNE1-targeted therapy may be beneficial for patients with endometrial endometrioid carcinoma having CCNE1 amplification.
|
| 巻・号 |
48(2)
|
| ページ |
506-16
|
| 公開日 |
2016-2-1
|
| DOI |
10.3892/ijo.2015.3268
|
| PMID |
26647729
|
| PMC |
PMC4725452
|
| MeSH |
Adaptor Proteins, Signal Transducing / genetics
Adult
Aged
Aged, 80 and over
Carcinoma, Endometrioid / genetics*
Cell Cycle Proteins / genetics
Cyclin E / genetics*
DNA-Binding Proteins
Disease-Free Survival
Endometrial Neoplasms / genetics*
F-Box Proteins / genetics
F-Box-WD Repeat-Containing Protein 7
Female
Gene Amplification / genetics*
Humans
Immunohistochemistry / methods
Middle Aged
MutL Protein Homolog 1
Nuclear Proteins / genetics
Oncogene Proteins / genetics*
PTEN Phosphohydrolase / genetics
Receptor, ErbB-2 / genetics
Transcription Factors / genetics
Tumor Suppressor Protein p53 / genetics
Ubiquitin-Protein Ligases / genetics
|
| IF |
3.899
|
| 引用数 |
10
|
|
WOS 分野
|
ONCOLOGY
|
| リソース情報 |
| ヒト・動物細胞 |
HHUA(RCB0658) |
